Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Carboplatin + Nab-paclitaxel / Protein-bound paclitaxel + Pembrolizumab & Non-Small-Cell Lung Carcinoma (NSCLC) (Squamous Cell Carcinoma), there is an explicit FDA and EMA approval for Carboplatin + Nab-paclitaxel / Protein-bound paclitaxel + Pembrolizumab as first‑line treatment for metastatic Non-Small-Cell Lung Carcinoma (NSCLC) (Squamous Cell Carcinoma) (1, 2).
In U.S. Oncology Practices, real-world outcomes have shown that patients with…